Eli Lilly and Company, AbbVie, Merck & Co., Inc., Pfizer, D-Wave Quantum, Johnson & Johnson, and Amgen are the seven ...

The Cambridge-based biotech's experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, ...

The InSiDe instrument has now been employed in clinical feasibility studies in France and the Netherlands for assessing ...

Wave Life Sciences’ experimental treatment for Duchenne muscular dystrophy hit the mark in a mid-stage study, setting the ...

Wave Life Sciences (WVE) stock rises on plans to file for FDA accelerated approval of WVE-N531 in 2026, targeting Duchenne muscular dystrophy. Read more here.

Abbott is officially bringing the noise—literally—by launching a clinical trial for its new intravascular lithotripsy (IVL) ...

Background: This editorial builds on a study by Brulin and Teoh, released ahead of the March/April 2025 issue of Annals of Family Medicine, which found that performance-based reimbursement is ...

A 76-year-old woman presents with a persistently rapid heart rate that she attributes to her pacemaker. What does the ECG ...

A new study reveals that encapsulated heating methods, an often-used heat simulation method, significantly increase heart rates and cardiac strain compared to natural heat exposure like those ...

From brain health — through good sleep habits — to daily skin and dental care regimens, these experts provide simple tips for ...

Scientists have successfully tested a rapid, reliable method for assessment of heart disease risk. The method can measure 25 important markers in the blood simultaneously, such as cholesterol, in less ...

Dr. George Shaker has huge hopes for a small radar device he developed with a team of researchers at the University of ...